LXPB5268 combined with neoadjuvant chemotherapy in early-stage Triple-Negative Breast Cancer patients

First Author / 第一作者

Liang-Chih Liu

Institution / 單位

Department of Breast Surgery, China Medical University Hospital, Taichung City, Taiwan.

Audio / 音訊檔

Author Group / 作者群

Tzong-Der Way(2); Chin- Hua Lin(3); Ya-Hui Chen(3); Chung-Hsin Tseng(3); Pin-Hung Kuo(3); and Chiu-Heng Chen(3)

Author Group Institution/ 作者群單位

(2): Department of Life Sciences, China Medical University, Taichung City, Taiwan. (3): LAUNXP Biomedical Co., Ltd, Taichung City, Taiwan.

Category / 主題分類

Clinical Research

Keyword / 關鍵字

LXP5268, neoadjuvant chemotherapy, triple-negative breast cancer, tumor shrinkage rate, objective response rate, WES

Back to list